Menu
PhRMA President and CEO Steve Ubl and Joe Grogan, a former Trump assistant and director of the White House’s Domestic Policy Council, took aim at the 340B program in a pair of recent op-eds.

Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

Shannon Young, Associate Editor/Senior Writer 340B Report Views
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Column: Setting the Record Straight on 340B Growth

Alkermes, Biogen Exempt New States from 340B Contract Pharmacy Restrictions

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Quick verification required before signup

Site Footer Live